Controlled Study to Evaluate the Safety and Efficacy of Azficel-T for Vocal Fold Scarring and Age-Related Dysphonia

Trial ID or NCT#

NCT02120781

Status

not recruiting iconNOT RECRUITING

Purpose

The objectives of this study are to assess the safety of azficel-T treatment for dysphonia related to vocal fold function and to evaluate the efficacy of azficel-T for the treatment of dysphonia related to vocal fold function.

Official Title

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Azficel-T for the Treatment of Vocal Fold Scarring and Age-Related Dysphonia

Eligibility Criteria

Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Show Less

Investigator(s)

Edward J. Damrose, MD, FACS
Edward J. Damrose, MD, FACS
Laryngologist, Head and neck surgeon, Ear, nose, and throat specialist, Head and neck oncologist
Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Anesthesiology, Perioperative & Pain Medicine (MSD)

Contact us to find out if this trial is right for you.

Contact

Edward J Damrose, MD
650-725-6500

View on ClinicalTrials.gov